title: Cytosolic Ca2+ shifts as early markers of cytotoxicity.
abstract: The determination of the cytotoxic potential of new and so far unknown compounds as well as their metabolites is fundamental in risk assessment. A variety of strategic endpoints have been defined to describe toxin-cell interactions, leading to prediction of cell fate. They involve measurement of metabolic endpoints, bio-energetic parameters or morphological cell modifications. Here, we evaluated alterations of the free cytosolic Ca2+ homeostasis using the Fluo-4 dye and compared results with the metabolic cell viability assay Alamar Blue. We investigated a panel of toxins (As2O3, gossypol, H2O2, staurosporine, and titanium(IV)-salane complexes) in four different mammalian cell lines covering three different species (human, mouse, and African green monkey). All tested compounds induced an increase in free cytosolic Ca2+ within the first 5 s after toxin application. Cytosolic Ca2+ shifts occurred independently of the chemical structure in all tested cell systems and were persistent up to 3 h. The linear increase of free cytosolic Ca2+ within the first 5 s of drug treatment correlates with the EC25 and EC75 values obtained in Alamar Blue assays one day after toxin exposure. Moreover, a rise of cytosolic Ca2+ was detectable independent of induced cell death mode as assessed by caspase and poly(ADP-ribose) polymerase (PARP) activity in HeLa versus MCF-7 cells at very low concentrations. In conclusion, a cytotoxicity assay based on Ca2+ shifts has a low limit of detection (LOD), is less time consuming (at least 24 times faster) compared to the cell viability assay Alamar Blue and is suitable for high-troughput-screening (HTS).
authors: Institute of Pharmacology and Toxicology, University of Zurich-Vetsuisse, Winterthurerstrasse 260, Zurich, CH-8057, Switzerland. felix.althaus@vetpharm.uzh.ch.
authors: Philippe
authors: P
authors: Wyrsch
authors: Christian
authors: C
authors: Blenn
authors: Theresa
authors: T
authors: Pesch
authors: Sascha
authors: S
authors: Beneke
authors: Felix R
authors: FR
authors: Althaus
references: Mol Pharmacol. 1990 Jun;37(6):840-7
references: 2193225
references: Neuropharmacology. 1997 Sep;36(9):1149-56
references: 9364470
references: J Biol Chem. 2012 Mar 23;287(13):10650-10663
references: 22235111
references: Protein Cell. 2010 May;1(5):468-77
references: 21203962
references: Toxicol Lett. 2010 Mar 15;193(2):173-8
references: 20079407
references: Virus Res. 2011 Jan;155(1):376-80
references: 21093504
references: J Neurosci Res. 1998 Feb 1;51(3):293-308
references: 9486765
references: Nat Med. 2012 Mar 18;18(4):600-4
references: 22426419
references: Toxicol In Vitro. 2004 Oct;18(5):703-10
references: 15251189
references: Am Biotechnol Lab. 1993 Mar;11(4):48-50
references: 7763491
references: Cell Mol Life Sci. 2008 Feb;65(4):644-55
references: 18202825
references: Blood. 2008 Sep 1;112(5):1971-80
references: 18566329
references: Breast Cancer. 2014 Mar;21(2):223-30
references: 22711315
references: J Immunol Methods. 2000 Jun 23;240(1-2):79-92
references: 10854603
references: Toxicol Sci. 2011 Jan;119(1):3-19
references: 20829425
references: J Immunol Methods. 1997 May 26;204(2):205-8
references: 9212838
references: ChemMedChem. 2009 May;4(5):738-41
references: 19343766
references: Mol Cell Biol. 2012 Sep;32(17):3541-53
references: 22751932
references: Eur J Pharmacol. 2006 Oct 10;547(1-3):1-9
references: 16934799
references: Methods Mol Biol. 2009;552:269-78
references: 19513656
references: Biochem Biophys Res Commun. 2012 Mar 9;419(2):374-80
references: 22349510
references: Cancer Biol Ther. 2008 May;7(5):767-76
references: 18376141
references: Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18308-13
references: 17116882
references: Curr Opin Cell Biol. 2005 Apr;17(2):135-40
references: 15780589
references: Int J Oncol. 1993 Sep;3(3):473-6
references: 21573387
references: Toxicol Appl Pharmacol. 2009 Dec 1;241(2):173-81
references: 19695276
references: Biochemistry. 1984 Jul 31;23(16):3771-7
references: 6206890
references: Biochim Biophys Acta. 2009 May;1788(5):1176-87
references: 19306841
references: J Biol Chem. 1992 Sep 15;267(26):18858-65
references: 1326536
references: Toxicology. 2006 Feb 15;219(1-3):167-74
references: 16337724
references: Cell Death Differ. 2004 Jul;11(7):737-46
references: 15002036
references: Cell Death Differ. 1998 Mar;5(3):191-9
references: 10200464
references: Front Med. 2012 Jun;6(2):156-64
references: 22660976
references: Apoptosis. 2011 Nov;16(11):1177-93
references: 21847655
references: Pharmacol Rev. 1998 Sep;50(3):413-92
references: 9755289
references: Arch Toxicol. 2004 Oct;78(10):549-64
references: 15170526
references: Mol Cancer. 2008 Feb 14;7:20
references: 18275607
references: Endocrinology. 2004 Dec;145(12):5568-79
references: 15319352
references: Biochem Cell Biol. 2005 Jun;83(3):354-64
references: 15959561
references: Biochem Biophys Res Commun. 1986 Mar 13;135(2):397-402
references: 3457562
references: Crit Rev Toxicol. 2009;39(7):553-75
references: 19650717
references: Methods Mol Biol. 2012;817:143-63
references: 22147572
references: J Cell Biol. 1991 Jan;112(2):279-88
references: 1988462
references: Cell Mol Life Sci. 2011 Apr;68(8):1455-66
references: 20878536
references: Methods Mol Biol. 2011;731:219-36
references: 21516411
references: Toxicol Appl Pharmacol. 2007 May 1;220(3):292-301
references: 17376498
references: Trends Pharmacol Sci. 1989 Jun;10(6):218-20
references: 2672462
references: Methods Enzymol. 2006;409:493-510
references: 16793420
references: Curr Drug Metab. 2010 Sep;11(7):595-602
references: 20812903
references: J Biochem Toxicol. 1986 Mar;1(1):29-39
references: 3271869
references: Biochem Biophys Res Commun. 1990 Aug 31;171(1):189-95
references: 2393390
references: J Immunol Methods. 1998 Apr 15;213(2):157-67
references: 9692848